India Pharmaceutical Regulatory Report 2010

Pacific Bridge Medical
April 1, 2011
65 Pages - SKU: PACB6483378
License type:
Countries covered: India

The India Pharmaceutical Regulatory Report comprehensively covers all aspects of pharmaceutical regulations in India. It includes overviews of the laws and procedures on registration, manufacturing, distribution, price control, marketing, research and development, and intellectual property protection. It also includes an overview of the Indian pharmaceutical market and foreign involvement in the market up to 2011. As India’s pharmaceutical market is poised for steady growth, reaching an estimated $13 billion, understanding of Indian regulatory issues is crucial for success.


More India Regulation & Policy Reports

Pricing and Reimbursement of the Healthcare System in India - Low Levels of Drug Reimbursement Lead to a High Out-Of-Pocket Expenditure by GBI Research
Pricing and Reimbursement of the Healthcare System in India - Low Levels of Drug Reimbursement Lead to a High Out-Of-Pocket Expenditure Summary GBI Research, the leading business ...

India Drug Patent Inventor Report by DrugPatentWatch
The India Drug Patent Inventor Report profiles Indian inventors who have been awarded pharmaceutical drug patents by the USPTO for FDA-approved drugs since 2000. ...

BRIC: Pricing, Reimbursment, and Regulatory Update by Datamonitor
Datamonitor’s report BRIC: Pricing, Reimbursement, and Regulatory Update provides an update of changes to pricing, reimbursement and regulation in Brazil, Russia, India and China during ...

Pharmaceutical Market in India by 2020: A Healthy Decade by IKON Marketing Consultants
This report begins with the current scenario of Pharmaceutical market in India with current market size and structure, market drivers, challenges and competitive landscape. ...

Top 20 Contract Research Organizations (CRO) - Asia-Pacific, Especially India and China, Positioned to Benefit from Rising Financial and Regulatory Pressures in Western Pharmaceutical Markets by GBI Research
Top 20 Contract Research Organizations (CRO) - Asia-Pacific, Especially India and China, Positioned to Benefit from Rising Financial and Regulatory Pressures in Western Pharmaceutical Markets Summary GBI ...

See all reports like this >>

More India Reports

D&B Country RiskLine Report: India by Dun & Bradstreet Inc.
This D&B Country RiskLine Report will help you analyze the risks, opportunities and likely payment delays when doing business in this country. It includes ...

D&B Country Report: India by Dun & Bradstreet Inc.
D&B Country Report. Comprehensive information for evaluating risks and opportunities when trading or investing in this country. Providing critical information and analysis on ...

Country Report India January 2011 by Economist Intelligence Unit
Country Reports analyse political and economic trends in featured countries. They show you exactly how national, regional and global events will affect your business in ...

Spirits - BRIC (Brazil, Russia, India, China) Industry Guide by MarketLine
Datamonitor's Spirits - BRIC (Brazil, Russia, India, China) Industry Guide is an essential resource for top-level data and analysis covering the BRIC (Brazil, Russia, India, ...

Wine - BRIC (Brazil, Russia, India, China) Industry Guide by MarketLine
Datamonitor's Wine - BRIC (Brazil, Russia, India, China) Industry Guide is an essential resource for top-level data and analysis covering the BRIC (Brazil, Russia, India, ...

See all reports like this >>